DK0642344T3 - Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering. - Google Patents

Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering.

Info

Publication number: DK0642344T3
Authority: DK; Denmark
Prior art keywords: dry powder; pct; oral suspension; suspension formulation; stable dry
Prior art date: 1992-04-30

Application number

DK93910771.0T

Other languages

English (en)

Inventor

Joel A Sequeira

Rebecca Galeos

Donald A Johnson

Lorraine Wearley

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-30

Filing date

1993-04-30

Publication date

1997-07-07

1993-04-30 Application filed by Schering Corp filed Critical Schering Corp

1997-07-07 Application granted granted Critical

1997-07-07 Publication of DK0642344T3 publication Critical patent/DK0642344T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)

DK93910771.0T 1992-04-30 1993-04-30 Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering. DK0642344T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US87688192A	1992-04-30	1992-04-30

Publications (1)

Publication Number	Publication Date
DK0642344T3 true DK0642344T3 (da)	1997-07-07

Family

ID=25368763

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93910771.0T DK0642344T3 (da)	1992-04-30	1993-04-30	Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering.

Country Status (22)

Country	Link
US (1)	US5599557A (da)
EP (1)	EP0642344B1 (da)
JP (1)	JP3378004B2 (da)
KR (1)	KR100257803B1 (da)
AT (1)	ATE150310T1 (da)
AU (1)	AU674516B2 (da)
CA (1)	CA2134467A1 (da)
CZ (1)	CZ283428B6 (da)
DE (1)	DE69309052T2 (da)
DK (1)	DK0642344T3 (da)
EE (1)	EE03039B1 (da)
ES (1)	ES2099438T3 (da)
FI (1)	FI945081A0 (da)
GR (1)	GR3023516T3 (da)
HU (1)	HU215958B (da)
NO (1)	NO307594B1 (da)
NZ (1)	NZ252433A (da)
PL (1)	PL171630B1 (da)
RU (1)	RU2123863C1 (da)
SK (1)	SK279329B6 (da)
UA (1)	UA27899C2 (da)
WO (1)	WO1993021923A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2079327B1 (es) *	1994-12-13	1996-08-01	Lilly Sa	Formulaciones farmaceuticas de cefaclor.
KR100342943B1 (ko) *	1999-08-04	2002-07-02	민경윤	비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020197314A1 (en) *	2001-02-23	2002-12-26	Rudnic Edward M.	Anti-fungal composition
US7101573B2 (en) *	2001-09-28	2006-09-05	Mcneil-Pcc, Inc.	Simethicone solid oral dosage form
EP1648418A4 (en) *	2003-07-21	2011-11-16	Middlebrook Pharmaceuticals Inc	ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) *	2003-07-21	2013-12-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
EP1648415A4 (en) *	2003-07-21	2011-11-16	Middlebrook Pharmaceuticals Inc	ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005016311A1 (en) *	2003-08-11	2005-02-24	Advancis Pharmaceutical Corporation	Robust pellet
CA2535398C (en) *	2003-08-12	2013-11-12	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
EP1658034A4 (en) *	2003-08-29	2011-06-22	Middlebrook Pharmaceuticals Inc	ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005027877A1 (en) *	2003-09-15	2005-03-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
AU2004308419B2 (en) *	2003-12-24	2011-06-02	Victory Pharma, Inc.	Enhanced absorption of modified release dosage forms
US8715727B2 (en) *	2004-07-02	2014-05-06	Shionogi Inc.	Tablet for pulsed delivery
US8653145B2 (en) *	2005-09-22	2014-02-18	Eaton Scientific Systems, Ltd.	Method for alleviating climacteric symptoms
US8778924B2 (en) *	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en)	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
US20100048609A1 (en) *	2006-08-01	2010-02-25	Jacobs Jeffrey W	Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
FR2911506B1 (fr) *	2007-01-18	2009-07-03	Ceva Sante Animale Sa	Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en)	2007-02-09	2015-04-07	Ceva Sante Animale	Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
EP2172223B1 (en) *	2007-06-22	2020-12-16	Kaneka Corporation	Composition containing physiologically active substance
US20110123505A1 (en) *	2007-08-22	2011-05-26	Kaneka Corporation	Method of producing reduced coenzyme q10 and method of stabilizing the same
WO2011139253A2 (en) *	2010-05-04	2011-11-10	Mahmut Bilgic	Pharmaceutical compositions comprising ceftibuten
RU2550932C1 (ru) *	2014-03-18	2015-05-20	Александр Александрович Кролевец	Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
GB202306826D0 (en)	2023-05-09	2023-06-21	Adjutec Pharma As	Therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3549746A (en) *	1967-11-02	1970-12-22	Bristol Myers Co	Antibiotic composition
US3780195A (en) *	1969-10-22	1973-12-18	Balchem Corp	Encapsulation process
US4016254A (en) *	1972-05-19	1977-04-05	Beecham Group Limited	Pharmaceutical formulations
GB1561301A (en) *	1976-01-02	1980-02-20	Beecham Group Ltd	Orally administrable pharmaceutical composition
US4321253A (en) *	1980-08-22	1982-03-23	Beatty Morgan L	Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
IE58110B1 (en) *	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
IT1183574B (it) *	1985-05-08	1987-10-22	Eurand Spa	Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
NZ220764A (en) *	1986-07-02	1989-09-27	Shionogi & Co	Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US4803082A (en) *	1987-10-28	1989-02-07	Warner-Lambert Company	Flavor and sweetness enhancement delivery systems and method of preparation
US5112604A (en) *	1989-09-01	1992-05-12	Riker Laboratories, Inc.	Oral suspension formulation

1993
- 1993-04-30 US US08/325,400 patent/US5599557A/en not_active Expired - Lifetime
- 1993-04-30 HU HU9403108A patent/HU215958B/hu not_active IP Right Cessation
- 1993-04-30 UA UA94119040A patent/UA27899C2/uk unknown
- 1993-04-30 FI FI945081A patent/FI945081A0/fi unknown
- 1993-04-30 DK DK93910771.0T patent/DK0642344T3/da active
- 1993-04-30 NZ NZ252433A patent/NZ252433A/en unknown
- 1993-04-30 DE DE69309052T patent/DE69309052T2/de not_active Expired - Lifetime
- 1993-04-30 CA CA002134467A patent/CA2134467A1/en not_active Abandoned
- 1993-04-30 SK SK1311-94A patent/SK279329B6/sk unknown
- 1993-04-30 RU RU94046038A patent/RU2123863C1/ru active
- 1993-04-30 JP JP51941393A patent/JP3378004B2/ja not_active Expired - Lifetime
- 1993-04-30 CZ CZ942636A patent/CZ283428B6/cs not_active IP Right Cessation
- 1993-04-30 ES ES93910771T patent/ES2099438T3/es not_active Expired - Lifetime
- 1993-04-30 AU AU41152/93A patent/AU674516B2/en not_active Ceased
- 1993-04-30 PL PL93305809A patent/PL171630B1/pl unknown
- 1993-04-30 AT AT93910771T patent/ATE150310T1/de not_active IP Right Cessation
- 1993-04-30 WO PCT/US1993/003856 patent/WO1993021923A1/en not_active Ceased
- 1993-04-30 EP EP93910771A patent/EP0642344B1/en not_active Expired - Lifetime
1994
- 1994-10-28 NO NO944113A patent/NO307594B1/no not_active IP Right Cessation
- 1994-10-29 KR KR1019940703864A patent/KR100257803B1/ko not_active Expired - Fee Related
- 1994-11-21 EE EE9400249A patent/EE03039B1/xx unknown
1997
- 1997-05-23 GR GR970401164T patent/GR3023516T3/el unknown

Also Published As

Publication number	Publication date
AU674516B2 (en)	1997-01-02
DE69309052T2 (de)	1997-06-19
SK279329B6 (sk)	1998-10-07
HK1002407A1 (en)	1998-08-21
JPH07506366A (ja)	1995-07-13
JP3378004B2 (ja)	2003-02-17
NZ252433A (en)	1996-07-26
HU215958B (hu)	1999-03-29
KR950701224A (ko)	1995-03-23
HUT71226A (en)	1995-11-28
PL171630B1 (pl)	1997-05-30
CZ263694A3 (en)	1995-04-12
RU2123863C1 (ru)	1998-12-27
US5599557A (en)	1997-02-04
NO944113D0 (no)	1994-10-28
SK131194A3 (en)	1995-07-11
KR100257803B1 (en)	2000-08-01
NO307594B1 (no)	2000-05-02
NO944113L (no)	1994-10-28
FI945081L (fi)	1994-10-28
RU94046038A (ru)	1996-11-10
WO1993021923A1 (en)	1993-11-11
EP0642344A1 (en)	1995-03-15
AU4115293A (en)	1993-11-29
GR3023516T3 (en)	1997-08-29
CZ283428B6 (cs)	1998-04-15
EE03039B1 (et)	1997-10-15
HU9403108D0 (en)	1995-02-28
ES2099438T3 (es)	1997-05-16
UA27899C2 (uk)	2000-10-16
DE69309052D1 (de)	1997-04-24
FI945081A7 (fi)	1994-10-28
ATE150310T1 (de)	1997-04-15
EP0642344B1 (en)	1997-03-19
CA2134467A1 (en)	1993-11-11
FI945081A0 (fi)	1994-10-28

Publication	Publication Date	Title
NO944113L (no)	1994-10-28	Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering
BG103518A (en)	2000-01-31	2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
ES8608864A1 (es)	1986-07-16	Un procedimiento para producir un preparado a modo de hojas
DE69318503D1 (de)	1998-06-18	Ein definiertes lipidsystem enthaltende pharmazeutische zusammensetzung
HUT37418A (en)	1985-12-28	Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
DE3783356D1 (de)	1993-02-11	Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
IL102814A0 (en)	1993-01-31	Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
GR1002907B (el)	1998-05-13	Επικαλυμμενο δισκιο μηλεινικης τριμεβουτινης
MY115429A (en)	2003-06-30	Fenbendazole formulations
UA74388C2 (uk)	2005-12-15	Фармацевтичні композиції тизоксаніду і нітазоксаніду
ES8404852A1 (es)	1984-05-16	Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
HUP0001773A2 (hu)	2000-11-28	Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
DE3474024D1 (en)	1988-10-20	Contraceptive compositions based on esters of levo-norgestrel
PL308580A1 (en)	1995-11-27	Solid pharmaceutical composition for oral administration and method of preparing same
HU9302813D0 (en)	1993-12-28	Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients
TR199900013T2 (xx)	1999-04-21	Yeni bile�ikler.
ES2087178T3 (es)	1996-07-16	Disulfato de ws7622a, procedimiento para su preparacion y su uso.
IL67400A0 (en)	1983-05-15	3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
EP0170024A3 (en)	1990-01-31	Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
HU903014D0 (en)	1990-09-28	Herbicide compositions containing 2-phenyl-perhydro-isoindol-1-one or -1-thione derivatives as active ingredient and process for the preparation of 2-phenyl-perhydro-isoindol-1-one and -1-thione derivatives
ITMI911653A1 (it)	1992-12-17	Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.